Neuroimaging of dementia

John A. Bertelson, Bela Ajtai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Dementia, whether secondary to Alzheimer disease or another process, is a significant cause of morbidity and mortality worldwide. Although dementia remains a clinical diagnosis, for many years imaging has served as a key component in the assessment of patients with cognitive impairment. There have been tremendous advancements in the neuroimaging of dementia over the past decade, moving the field past the rule-out dogma toward ruling in specific pathophysiologic processes. This article is written for the practicing clinician, to provide a review of neuroimaging findings associated with selected degenerative and nondegenerative forms of dementia.

Original languageEnglish (US)
Pages (from-to)59-93
Number of pages35
JournalNeurologic Clinics
Volume32
Issue number1
DOIs
StatePublished - Feb 2014

Fingerprint

Neuroimaging
Dementia
Alzheimer Disease
Morbidity
Mortality

Keywords

  • Alzheimer disease (AD)
  • Frontotemporal lobar degeneration (FTLD)
  • Lewy body dementia (LBD)
  • Magnetic resonance imaging (MRI)
  • Multiple sclerosis (MS)
  • Positron emission tomography (PET)
  • Prion disease
  • Vascular cognitive impairment

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Bertelson, J. A., & Ajtai, B. (2014). Neuroimaging of dementia. Neurologic Clinics, 32(1), 59-93. https://doi.org/10.1016/j.ncl.2013.07.001

Neuroimaging of dementia. / Bertelson, John A.; Ajtai, Bela.

In: Neurologic Clinics, Vol. 32, No. 1, 02.2014, p. 59-93.

Research output: Contribution to journalArticle

Bertelson, JA & Ajtai, B 2014, 'Neuroimaging of dementia', Neurologic Clinics, vol. 32, no. 1, pp. 59-93. https://doi.org/10.1016/j.ncl.2013.07.001
Bertelson, John A. ; Ajtai, Bela. / Neuroimaging of dementia. In: Neurologic Clinics. 2014 ; Vol. 32, No. 1. pp. 59-93.
@article{762ea944cfc54892b846eccc5f3bf068,
title = "Neuroimaging of dementia",
abstract = "Dementia, whether secondary to Alzheimer disease or another process, is a significant cause of morbidity and mortality worldwide. Although dementia remains a clinical diagnosis, for many years imaging has served as a key component in the assessment of patients with cognitive impairment. There have been tremendous advancements in the neuroimaging of dementia over the past decade, moving the field past the rule-out dogma toward ruling in specific pathophysiologic processes. This article is written for the practicing clinician, to provide a review of neuroimaging findings associated with selected degenerative and nondegenerative forms of dementia.",
keywords = "Alzheimer disease (AD), Frontotemporal lobar degeneration (FTLD), Lewy body dementia (LBD), Magnetic resonance imaging (MRI), Multiple sclerosis (MS), Positron emission tomography (PET), Prion disease, Vascular cognitive impairment",
author = "Bertelson, {John A.} and Bela Ajtai",
year = "2014",
month = "2",
doi = "10.1016/j.ncl.2013.07.001",
language = "English (US)",
volume = "32",
pages = "59--93",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Neuroimaging of dementia

AU - Bertelson, John A.

AU - Ajtai, Bela

PY - 2014/2

Y1 - 2014/2

N2 - Dementia, whether secondary to Alzheimer disease or another process, is a significant cause of morbidity and mortality worldwide. Although dementia remains a clinical diagnosis, for many years imaging has served as a key component in the assessment of patients with cognitive impairment. There have been tremendous advancements in the neuroimaging of dementia over the past decade, moving the field past the rule-out dogma toward ruling in specific pathophysiologic processes. This article is written for the practicing clinician, to provide a review of neuroimaging findings associated with selected degenerative and nondegenerative forms of dementia.

AB - Dementia, whether secondary to Alzheimer disease or another process, is a significant cause of morbidity and mortality worldwide. Although dementia remains a clinical diagnosis, for many years imaging has served as a key component in the assessment of patients with cognitive impairment. There have been tremendous advancements in the neuroimaging of dementia over the past decade, moving the field past the rule-out dogma toward ruling in specific pathophysiologic processes. This article is written for the practicing clinician, to provide a review of neuroimaging findings associated with selected degenerative and nondegenerative forms of dementia.

KW - Alzheimer disease (AD)

KW - Frontotemporal lobar degeneration (FTLD)

KW - Lewy body dementia (LBD)

KW - Magnetic resonance imaging (MRI)

KW - Multiple sclerosis (MS)

KW - Positron emission tomography (PET)

KW - Prion disease

KW - Vascular cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=84888172632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888172632&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2013.07.001

DO - 10.1016/j.ncl.2013.07.001

M3 - Article

C2 - 24287385

AN - SCOPUS:84888172632

VL - 32

SP - 59

EP - 93

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 1

ER -